Literature DB >> 25149131

Neurocognition in schizophrenia: from prodrome to multi-episode illness.

Valentina Corigliano1, Antonella De Carolis2, Giada Trovini3, Julia Dehning3, Simone Di Pietro3, Martina Curto3, Nicole Donato2, Eleonora De Pisa3, Paolo Girardi3, Anna Comparelli3.   

Abstract

Individuals with schizophrenia present a neuropsychological deficit throughout the course of the disorder. Few studies have addressed the progression of the deficit since the prodromal phase of the disorder. This investigation explored neurocognition in accordance with the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus recommendations. The aim of the study was to explore the presence of neurocognitive impairment in ultra-high-risk individuals and the stage of this impairment in samples at different phases of illness. Thirty-six individuals with a prodromal syndrome, 53 first-episode and 44 multi-episode schizophrenia patients were assessed to examine neuropsychological performance. ANCOVA analysis adjusted for possible confounder factors and planned contrasts with healthy controls were undertaken. The results revealed deficits in speed-of-processing, visual-learning and social-cognition in prodromal individuals, and of all other neuropsychological domains in both first-episode and multi-episode patients. Furthermore impairment was found in the first-episode and in the multi-episode group, respectively on working-memory and attention. Within the framework of the neurodevelopmental model of schizophrenia, our results suggest the presence of neuropsychological impairment before the onset of full-blown psychosis. Moreover, the deficits are larger in the more chronic groups, according to the theory of an ongoing neurodevelopmental alteration.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Early psychosis; First-episode schizophrenia; MATRICS; Neurocognitive impairment; Neurodevelopmental model; Ultra-high risk

Mesh:

Year:  2014        PMID: 25149131     DOI: 10.1016/j.psychres.2014.07.067

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  13 in total

1.  Treatment with levetiracetam improves cognition in a ketamine rat model of schizophrenia.

Authors:  Ming Teng Koh; Yi Shao; Sharon Rosenzweig-Lipson; Michela Gallagher
Journal:  Schizophr Res       Date:  2017-06-17       Impact factor: 4.939

Review 2.  Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials.

Authors:  Y Iwata; S Nakajima; T Suzuki; R S E Keefe; E Plitman; J K Chung; F Caravaggio; M Mimura; A Graff-Guerrero; H Uchida
Journal:  Mol Psychiatry       Date:  2015-06-16       Impact factor: 15.992

3.  The Relationship between Cognitive Functions and Psychopathological Symptoms in First Episode Psychosis and Chronic Schizophrenia.

Authors:  Katarzyna Rek-Owodziń; Ernest Tyburski; Piotr Plichta; Katarzyna Waszczuk; Maksymilian Bielecki; Krzysztof Wietrzyński; Piotr Podwalski; Krzysztof Rudkowski; Anna Michalczyk; Tomasz Grąźlewski; Leszek Sagan; Jolanta Kucharska-Mazur; Jerzy Samochowiec; Monika Mak
Journal:  J Clin Med       Date:  2022-05-06       Impact factor: 4.964

4.  Impaired hippocampal-dependent memory and reduced parvalbumin-positive interneurons in a ketamine mouse model of schizophrenia.

Authors:  Ming Teng Koh; Yi Shao; Andrew Sherwood; Dani R Smith
Journal:  Schizophr Res       Date:  2016-01-19       Impact factor: 4.939

5.  Suicidal ideation in first-episode psychosis: Considerations for depression, positive symptoms, clinical insight, and cognition.

Authors:  Lindsay A Bornheimer; Jessica A Wojtalik; Juliann Li; Derin Cobia; Matthew J Smith
Journal:  Schizophr Res       Date:  2021-01-23       Impact factor: 4.939

6.  Social Cognition in Individuals at Ultra-High Risk for Psychosis: A Meta-Analysis.

Authors:  R J M van Donkersgoed; L Wunderink; R Nieboer; A Aleman; G H M Pijnenborg
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

7.  The Korean Version of the Schizophrenia Cognition Rating Scale: Reliability and Validity.

Authors:  Eun-Chan Kang; Sung-Jin Kim; Young-Soo Seo; Sung-Soo Jung; Beom-Joo Seo; Jeoung-Whan Ryu; Joo-Cheol Shim; Jung-Joon Moon; Dong-Wook Jeon; Kyoung-Duck Park; Do-Un Jung
Journal:  Psychiatry Investig       Date:  2017-03-06       Impact factor: 2.505

8.  Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D3 Receptor Blockade.

Authors:  Sebastiano Alfio Torrisi; Salvatore Salomone; Federica Geraci; Filippo Caraci; Claudio Bucolo; Filippo Drago; Gian Marco Leggio
Journal:  Front Pharmacol       Date:  2017-10-04       Impact factor: 5.810

9.  Global and Specific Profiles of Executive Functioning in Prodromal and Early Psychosis.

Authors:  Wu Jeong Hwang; Tae Young Lee; Won-Gyo Shin; Minah Kim; Jihyang Kim; Junhee Lee; Jun Soo Kwon
Journal:  Front Psychiatry       Date:  2019-05-21       Impact factor: 4.157

10.  Metacognition-augmented cognitive remediation training reduces jumping to conclusions and overconfidence but not neurocognitive deficits in psychosis.

Authors:  Steffen Moritz; Teresa Thoering; Simone Kühn; Bastian Willenborg; Stefan Westermann; Matthias Nagel
Journal:  Front Psychol       Date:  2015-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.